Los Angeles Times: Judge Again Rejects Limits On Crisis Contraception In just one more scathing critique of federal government health officials, a federal judge refused Friday to stay his order making crisis contraceptives open to consumers of most ages without a prescription. Calling authorities attempts to restrict the sale of medicines such as Strategy B frivolous and taken for the purpose of delay, U.S. District Judge Edward R. Korman of New York wrote that the medicines would be open to all unless the next Circuit Courtroom of Appeals ruled usually by noon Eastern time on Monday . Related StoriesHeart of the Rockies Regional INFIRMARY selects Aprima EHRStudy: Post hospital syndrome can be significant risk element for patients undergoing elective surgeryBoston Kids's and Rock Health team up to accelerate development of pediatric health technology And a Supreme Court justice gives a astonishing retrospective of Roe v.The Stage 1/2a trial comes after the effective completion of the Phase 1 trial of AST-OPC1, which met its major endpoints of feasibility and safety when administered to five patients with neurologically complete, thoracic SCI. Shepherd Middle was a site in the Phase 1 research and enrolled two of the five subjects in that study. Asterias intends to initiate enrollment for the Stage 1/2a trial at up to seven additional sites in the arriving months. ‘The Phase 1 study generated a strong bundle of data regarding the protection of AST-OPC1,’ said Donald Peck Leslie, M.D., medical director of Shepherd Middle and principal investigator because of this scholarly study site.